Pliant Therapeutics (PLRX) EBITDA Margin (2020 - 2023)
Pliant Therapeutics (PLRX) reported EBITDA Margin of 16976.61% for Q2 2023, down 1637820.0% year-over-year from N/an in Q2 2022, and down 512.47% quarter-over-quarter from 2771.85% in Q1 2023.
Pliant Therapeutics (PLRX) EBITDA Margin (2020 - 2023) Analysis & Trends
Pliant Therapeutics (PLRX) has 4 years of EBITDA Margin data on file, last reported at 16976.61% in Q2 2023.
- EBITDA Margin for Q2 2023 came in at 16976.61%, down 1637820.0% year-over-year; the trailing twelve-month figure through Mar 2024 was 68508.47% (down 6714534.0% YoY), and the FY2023 annual result was 10065.38%, down 877392.0% from the prior year.
- EBITDA Margin slipped to 16976.61% in Q2 2023 per PLRX's latest filing, from 2771.85% in the prior quarter.
- Over five years, EBITDA Margin peaked at 38.32% in Q1 2020 and troughed at 16976.61% in Q2 2023.
- A 4-year average of 2357.95% and a median of 1256.04% in 2021 frame the typical range for EBITDA Margin.
- The sharpest annual moves came in 2022 and 2023: EBITDA Margin soared 67844 bps in 2022, then slumped 1637820 bps in 2023.
- A 4-year view of EBITDA Margin shows it stood at 426.45% in 2020, then tumbled by 190 bps to 1235.22% in 2021, then tumbled by 42 bps to 1758.98% in 2022, then plunged by 865 bps to 16976.61% in 2023.
- Business Quant data shows PLRX's EBITDA Margin at 16976.61% in Q2 2023, 2771.85% in Q1 2023, and 1758.98% in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -6.43% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Pliant Therapeutics | 71.07 Mn | 71.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -16,976.61% |
| Mar 31, 2023 | -2,771.85% |
| Dec 31, 2022 | -1,758.98% |
| Sep 30, 2022 | -2,146.42% |
| Jun 30, 2022 | -598.42% |
| Mar 31, 2022 | -2,309.77% |
| Dec 31, 2021 | -1,235.22% |
| Sep 30, 2021 | -1,680.43% |
| Jun 30, 2021 | -1,276.86% |
| Mar 31, 2021 | -1,050.69% |
| Dec 31, 2020 | -426.45% |
| Sep 30, 2020 | -343.21% |
| Jun 30, 2020 | -474.72% |
| Mar 31, 2020 | 38.32% |